4025 — Taki Chemical Co Balance Sheet
0.000.00%
- ¥32bn
- ¥28bn
- ¥39bn
- 82
- 71
- 51
- 81
Annual balance sheet for Taki Chemical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6,426 | 6,533 | 6,256 | 5,075 | 7,458 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9,788 | 10,846 | 12,185 | 11,469 | 12,805 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21,898 | 22,352 | 26,039 | 23,784 | 27,274 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 13,878 | 15,809 | 15,312 | 16,380 | 16,990 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 42,939 | 46,037 | 50,323 | 51,299 | 58,402 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,313 | 8,596 | 9,973 | 8,503 | 10,489 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 16,003 | 16,801 | 18,374 | 17,479 | 20,520 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 26,936 | 29,236 | 31,949 | 33,820 | 37,882 |
| Total Liabilities & Shareholders' Equity | 42,939 | 46,037 | 50,323 | 51,299 | 58,402 |
| Total Common Shares Outstanding |